This document is an excerpt from the EUR-Lex website
Document 32012M6453
Commission Decision of 22/03/2012 declaring a concentration to be compatible with the common market (Case No COMP/M.6453 - CARLYLE / DR.AXEL PAEGER / QUADRIGA CAPITAL IV / AMEOS) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic)
Decisione della Commissione, del 22/03/2012 che dichiara la compatibilità con il mercato comune di una concentrazione (Caso n. COMP/M.6453 - CARLYLE / DR.AXEL PAEGER / QUADRIGA CAPITAL IV / AMEOS) in base al Regolamento (CE) n. 139/2004 del Consiglio (Il testo in lingua inglese è il solo facente fede)
Decisione della Commissione, del 22/03/2012 che dichiara la compatibilità con il mercato comune di una concentrazione (Caso n. COMP/M.6453 - CARLYLE / DR.AXEL PAEGER / QUADRIGA CAPITAL IV / AMEOS) in base al Regolamento (CE) n. 139/2004 del Consiglio (Il testo in lingua inglese è il solo facente fede)
In force
32012M6453
Commission Decision of 22/03/2012 declaring a concentration to be compatible with the common market (Case No COMP/M.6453 - CARLYLE / DR.AXEL PAEGER / QUADRIGA CAPITAL IV / AMEOS) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic)
|EUROPEAN COMMISSION | Brussels , 22.3.2012 C(2012) 2082 final PUBLIC VERSION SIMPLIFIED MERGER PROCEDURE |To the notifying parties: | Dear Madam(s) and/or Sir(s), Subject: Case No COMP/M. M.6453-CARLYLE / DR.AXEL PAEGER / QUADRIGA CAPITAL IV / AMEOS Commission decision pursuant to Article 6(1)(b) of Council Regulation (EC) No 139/2004 [1] 1. On 16 February 2012, the European Commission received notification of a proposed concentration pursuant to Article 4 of the Merger Regulation by which funds managed by The Carlyle Group ("Carlyle", US), Dr. Axel Paeger and companies affiliated with Quadriga Capital Europe IV GP Ltd. ("Quadriga Capital IV", Jersey) acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of the whole of AMEOS Holding AG and AMEOS AG (together referred as "AMEOS", Switzerland) by way of purchase of shares. 2. The business activities of the undertakings concerned are: - for Carlyle: alternative asset manager, especially managing pension funds' sponsored assets. - for Dr. Axel Paeger: co-founder and – since foundation – Chief Executive Officer of AMEOS. - for Quadriga Capital IV: investment vehicle sponsored by pension funds and other institutional investors. - for AMEOS: operators of acute general and acute psychiatric hospitals as well as long-term elderly care and long-term mental care facilities in Germany and in Austria [2] . 3. After examination of the notification, the European Commission has concluded that the notified operation falls within the scope of the Merger Regulation and of paragraph 5 (b) of the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 [3] . 4. For the reasons set out in the Notice on a simplified procedure, the European Commission has decided not to oppose the notified operation and to declare it compatible with the internal market and with the EEA Agreement. This decision is adopted in application of Article 6(1)(b) of the Merger Regulation. For the Commission (signed) Alexander ITALIANER Director General [1]OJ L 24, 29.1.2004, p. 1 ("the Merger Regulation"). With effect from 1 December 2009, the Treaty on the Functioning of the European Union ("TFEU") has introduced certain changes, such as the replacement of "Community" by "Union" and "common market" by "internal market". The terminology of the TFEU will be used throughout this decision. [2] Publication in the Official Journal of the European Union No C 62, 1.03.2012, p.4 [3] OJ C 56, 5.3.2005, p. 32.